The program would include a 60-day comment period in which anyone could submit additional data or refute the claim. GMA said such a system would reduce the burden on FDA while “still requiring the same level of pertinent research and safety information” by those making the claim as well as stringent FDA review. If approved, the claim could be used by any food or beverage company. FDA could review the claim at its discretion based on new research.
